EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of BXSB lupus mice with fully matched allogeneic bone marrow transplantation using nonmyeloablative conditioning



Treatment of BXSB lupus mice with fully matched allogeneic bone marrow transplantation using nonmyeloablative conditioning



Pediatric Research 53(4 Part 2): 14A, April




(PDF 0-2 workdays service: $29.90)

Accession: 035980344

Download citation: RISBibTeXText



Related references

Nonmyeloablative bone marrow transplantation of BXSB lupus mice using fully matched allogeneic donor cells from green fluorescent protein transgenic mice. Journal of Immunology 172(9): 5415-5419, 2004

Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 74(1): 22-27, 2002

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches. Biology of Blood and Marrow Transplantation 7(12): 656-664, 2002

Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice. Experimental Hematology (Charlottesville) 27(10): 1503-1510, 1999

Invasive fungal infections in patients undergoing fully matched allogeneic stem cell transplantation following nonmyeloablative conditioning. Blood 94(10 SUPPL 1 PART 1): 339a, Nov 15, 1999

Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice. Zhonghua Xue Ye Xue Za Zhi 24(7): 372-375, 2003

Selective depletion of donor-reactive cells as a nonmyeloablative conditioning for allogeneic bone marrow transplantation. Experimental Hematology (Charlottesville) 30(6 Supplement 1): 133, June, 2002

Allogeneic bone marrow transplantation with a nonmyeloablative conditioning regimen in a patient with acute myeloblastic leukemia. Terapevticheskii Arkhiv 72(7): 67-67, 2000

Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?. Cancer Immunology, ImmunoTherapy 53(8): 659-676, 2004

Successful Nonmyeloablative Allogeneic Bone Marrow Transplantation for Donor-Derived De Novo Adult T-Cell Leukemia after Myeloablative Allogeneic Bone Marrow Transplantation from HTLV-I Positive Sibling Case Report. Blood 100(11): Abstract No 5379, November 16, 2002

Anti-tumor effects of allogeneic bone marrow transplantation with nonmyeloablative conditioning combined with donor lymphocyte infusion. Proceedings of the American Association for Cancer Research Annual Meeting 44: 762, July, 2003

Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency. Biology of Blood and Marrow Transplantation 11(10): 755-763, 2005

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation. Blood 105(7): 2991-2994, 2005

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation. Blood 105(7): 2991-2994, 2004

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biology of Blood and Marrow Transplantation 6(3a): 309-320, 2000